These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24016380)

  • 1. The "July effect" does not have clinical relevance in liver transplantation.
    Karipineni F; Panchal H; Khanmoradi K; Parsikhia A; Ortiz J
    J Surg Educ; 2013; 70(5):669-79. PubMed ID: 24016380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplant fellowship and resident training is not a part of the "July effect".
    Harring TR; Nguyen NT; Liu H; Goss JA; O'Mahony CA
    J Surg Res; 2013 Jun; 182(1):1-5. PubMed ID: 23478081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after liver transplantation in patients achieving a model for end-stage liver disease score of 40 or higher.
    Alexopoulos S; Matsuoka L; Cho Y; Thomas E; Sheikh M; Stapfer M; Dhanireddy K; Sher L; Selby R; Genyk Y
    Transplantation; 2013 Feb; 95(3):507-12. PubMed ID: 23380865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
    Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
    Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
    Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era.
    Lee WC; Chan KM; Chou HS; Wu TJ; Lee CF; Soong RS; Wu TH; Lee CS
    Ann Surg; 2013 Aug; 258(2):306-11. PubMed ID: 23108123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States.
    Yoo HY; Thuluvath PJ
    Liver Int; 2005 Jun; 25(3):536-41. PubMed ID: 15910490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
    Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of adult liver re-transplant patients in the model for end-stage liver disease era: is it time to reconsider its indications?
    Montenovo MI; Hansen RN; Dick AA
    Clin Transplant; 2014 Oct; 28(10):1099-104. PubMed ID: 25041109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved posttransplant mortality after share 35 for liver transplantation.
    Kwong AJ; Goel A; Mannalithara A; Kim WR
    Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ; Fikatas P; Schmidt J; Barreiros AP; Otto G; Beckebaum S; Paul A; Scherer MN; Schmidt HH; Schlitt HJ; Neuhaus P; Klempnauer J; Pratschke J; Manns MP; Strassburg CP
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.
    Kanwal F; Dulai GS; Spiegel BM; Yee HF; Gralnek IM
    Aliment Pharmacol Ther; 2005 Jan; 21(2):169-77. PubMed ID: 15679767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications and death at the start of the new academic year: is there a July phenomenon?
    Inaba K; Recinos G; Teixeira PG; Barmparas G; Talving P; Salim A; Brown C; Rhee P; Demetriades D
    J Trauma; 2010 Jan; 68(1):19-22. PubMed ID: 20065752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.